<DOC>
<DOCNO>
EP-0001503
</DOCNO>
<TEXT>
<DATE>
19790418
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/44 A61K-31/55 A61P-29/00 A61P-7/00 C07D-275/00 A61K-31/495 A61K-31/425 A61P-7/02 <main>A61K-31/44</main> A61K-31/445 A61K-31/535 A61K-31/60 C07D-275/04 
</IPC-CLASSIFICATIONS>
<TITLE>
antithrombotic compositions containing benzisothiazolones.
</TITLE>
<APPLICANT>
beecham group ltd gb <sep>beecham group limited<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group limited<sep>
</APPLICANT>
<INVENTOR>
baggaley keith howard<sep>nunn barbara<sep>baggaley, keith howard<sep>nunn, barbara<sep>baggaley, keith howard3 blackstone hillredhill surreygb<sep>nunn, barbara42 worcester roadsutton surreygb<sep>baggaley, keith howard<sep>nunn, barbara<sep>baggaley, keith howard3 blackstone hillredhill surreygb<sep>nunn, barbara42 worcester roadsutton surreygb<sep>
</INVENTOR>
<ABSTRACT>
this invention relates to a pharmaceutical composition  useful in the treatment of arterial thrombosis.  a combination  of a non-steroidal anti-inflammatory agent with a  benzisothiazolone of formula (i) is found to be capable of  inhibiting the aggregation of blood platelets to a greater  degree than each of the components separately.     r¹ and r² represent a variety of substituent groups; x represents  a bond or an alkylene chain; and r represents a  heterocyclic group.  when the anti-inflammatory agent contains a carboxylic  acid group, the combination with compound (i)  may be in the form of a salt.  
</ABSTRACT>
</TEXT>
</DOC>
